The study analyzed more than 4,000 COVID-19 hospitalizations of people with private insurance and Medicare Advantage insurance between March and September 2020.
While most health insurers in 2020 voluntarily waived co-pays, deductibles and other cost-sharing, many stopped the waivers in early 2021.
Without the waivers, people could owe $3,800 if they have job-related or self-purchased private insurance, or $1,500 if they have Medicare Advantage plans. In total, each hospitalization of a person with private insurance costs about $42,200 on average, and each hospitalization with Medicare Advantage costs about $21,400 on average.
The study also found that cost-sharing waivers don’t always cover all hospitalization care. Seventy-one percent of those with private insurance were charged an average of $788, and 49 percent of those with Medicare Advantage were charged an average of $277.
“Many insurers claim that it is justified to charge patients for COVID-19 hospitalizations now that COVID-19 vaccines are widely available,” said lead author Kao-Ping Chua, MD, PhD, in an Oct. 18 statement. “However, some people hospitalized for COVID-19 aren’t eligible for vaccines, such as young children, while others are vaccinated patients who experienced a severe breakthrough infection. Our study suggests these patients could [owe] substantial bills.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
